Michele Marin Appointed as New Member of the Italian Board of Directors

Food and Healthcare Press Releases Thursday May 3, 2018 11:42
SAN DANIELE DEL FRIULI, Italy--3 May--PRNewswire/InfoQuest

LimaCorporate has appointed Mr. Michele Marin as a Member of the Italian Board of Directors as of 27th April 2018 in replacement of Daniele Negrato. This appointment follows the previous announcement regarding Michele Marin appointment as CFO of LimaCorporate as of 1st March 2018.

(Logo: https://mma.prnewswire.com/media/637371/Lima_Corporate_Logo.jpg )

After having earned a Business Degree from the Ca' Foscari University of Venice, Michele started his career at PriceWaterhouseCoopers in 1995 and worked in different multinational companies until becoming CFO for Salmoiraghi & Vigano, the Italy-based optical retailer, in 2013. Following the acquisition of the company by Luxottica, he assumed to the role of Chief Accounting Officer for Luxottica in April 2017.

In addition to the functions within the Board of Directors and those as LimaCorporate's group CFO, Michele is in charge of the Legal Affairs and Compliance and the IT departments.
About LimaCorporate

LimaCorporate is a global medical device company providing reconstructive orthopedic solutions to surgeons who face the challenges of improving the quality of life of their patients. Based in Italy, LimaCorporate is committed to the development of innovative products and procedures to enable surgeons to select ideal solution for every individual patient. LimaCorporate's product range includes large joint revision and primary implants and complete extremities solutions including fixation.

For additional information on the Company, please visit: http://www.limacorporate.com
Limacorporate S.p.A.
Via Nazionale, 52
33038 Villanova di San Daniele
Udine - Italy
T: +39-0432-945-511
E: info@limacorporate.com
Source: Limacorporate S.p.A.

Latest Press Release

Merck Presents Updated Results for Bifunctional Immunotherapy M7824 at ESMO 2018 Congress

- New data presented at the ESMO 2018 Congress include first disclosure of results for M7824 in advanced squamous cell carcinoma of the head and neck, biliary tract cancer and esophageal cancers - Updated data also being presented include non-small cell...

Menarini Progresses Into the Clinic With MEN1611, a PI3K Inhibitor for the Treatment of HER2 Positive Metastatic Breast Cancer

Menarini Ricerche announced today the initiation of the B-PRECISE-01 clinical trial, a multicenter phase Ib study that will evaluate the safety and efficacy of MEN1611 plus trastuzumab with or without fulvestrant. The study will enroll patients with...

Don#t Miss the Signs of a Breaking Spine, Warns IOF

Osteoporosis, a disease which causes bones to become weak and fragile, is the cause of broken bones in approximately one in three women and one in five men aged over 50 worldwide. (Photo: https://mma.prnewswire.com/media/767079/IOF_Infographic.jpg...

Merck Inaugurates State-of-the-art Pharma Packaging Center in Darmstadt

- Expansion of the pharma manufacturing site at Merck's headquarters supports growth of current and future portfolio of pharma medicines - New building dedicated to the packaging and shipping of Merck's pharma medicines in more than 90 countries - EUR63...

Herbalife Nutrition Survey Reveals Secrets to Healthy Aging, Announces Wellness Tour to Kickstart APAC Consumers# Healthy Aging Journey

As a company whose purpose is to make the world healthier and happier, premier global nutrition company, Herbalife Nutrition, today released findings from its 2018 Asia Pacific Healthy Aging Survey. Conducted in August 2018 with 5,500 respondents aged 40...

Related Topics